ResMed | RMD - Los Gastos De Explotación





Los Gastos De Explotación Cambio Fecha
Ansell USD 880.1M 465.65M 2025-12
Artivion USD 111.2M 9.45M 2025-12
AtriCure USD 150.1M 6.16M 2026-09
Baxter International USD 6.5B 3.82B 2026-09
Cochlear AUD 914.9M 454.8M 2025-12
Cooper Companies USD 844.2M 268.3M 2026-06
CSL USD 5.7B 2.82B 2025-12
Dexcom USD 990.1M 53.5M 2026-06
Edwards Lifesciences USD 10.86B 9.64B 2026-09
Fisher Paykel Healthcare NZD 869.6M 67.2M 2026-06
Globus Medical USD 585.49M 250.09M 2026-09
Haemonetics USD 145.79M 448K 2026-09
Idexx Laboratories USD 811.89M 20.87M 2026-09
Inogen USD 49.14M 665K 2024-09
Insulet USD 652.2M 19.8M 2026-09
Integra LifeSciences USD 368.53M 674.84M 2026-09
Intuitive Surgical USD 2B 86.5M 2026-09
Medtronic USD 7.92B 203M 2026-06
Philips EUR 4.23B 478M 2026-09
Ramsay Health Care AUD 8.8B 83.5M 2025-12
ResMed USD 1.01B 83.57M 2026-06
Sigma Healthcare AUD 1.68B 174.89M 2024-12
Sonic Healthcare AUD 4.23B 2.14B 2024-12
Steris USD 1.27B 62.5M 2026-09
Teleflex USD 3.49B 589.18M 2026-09
Thermo Fisher Scientific USD 9.68B 134M 2026-09